{"id": 165, "relation": "0", "prompt": "Northern blot analysis of mRNA from normal and <e2> BPH </e2> stromal cells demonstrated a 5-fold decrease in <e1> IGFBP-2 mRNA </e1> (P &lt; 0.001) and a 4-fold increase in IGFBP-5 mRNA (P &lt; 0.01) in BPH compared to normal cells.\n\n###\n\n", "completion": " IGFBP-2 mRNA\nBPH\nfalse END"}
{"id": 166, "relation": "0", "prompt": "These findings are consistent with a role for increased DHT levels in the prostate through increased activity of the <e1> SRD5A2 locus </e1> in <e2> prostate cancer </e2> progression, in a subset of patients.\n\n###\n\n", "completion": " SRD5A2 locus\nprostate cancer\nfalse END"}
{"id": 167, "relation": "1", "prompt": "Inhibition of <e1> telomerase </e1> with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in <e2> prostate cancer </e2> cells.\n\n###\n\n", "completion": " telomerase\nprostate cancer\ntrue END"}
{"id": 168, "relation": "1", "prompt": "hTERT AS PS-ODN can significantly inhibit telomerase activity by downregulating the <e1> hTERT mRNA </e1> and protein expression, and inhibition of telomerase with hTERT antisense can enhance TNF-alpha-induced apoptosis of <e2> PC3 </e2> cells.\n\n###\n\n", "completion": " hTERT mRNA\nPC3\ntrue END"}
{"id": 169, "relation": "1", "prompt": "hTERT AS PS-ODN can significantly inhibit telomerase activity by downregulating the <e1> hTERT mRNA </e1> and protein expression, and inhibition of telomerase with hTERT antisense can enhance TNF-alpha-induced apoptosis of <e2> PC3 </e2> cells.\n\n###\n\n", "completion": " hTERT mRNA\nPC3\ntrue END"}
{"id": 170, "relation": "1", "prompt": "Inhibition of the <e1> Akt </e1> , cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for <e2> prostate cancer </e2> .\n\n###\n\n", "completion": " Akt\nprostate cancer\ntrue END"}
{"id": 171, "relation": "1", "prompt": "Inhibition of the Akt, <e1> cyclooxygenase-2 </e1> , and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for <e2> prostate cancer </e2> .\n\n###\n\n", "completion": " cyclooxygenase-2\nprostate cancer\ntrue END"}
{"id": 172, "relation": "0", "prompt": "Previous studies by us and others, with androgen-sensitive <e2> prostate cancer </e2> cell lines, have demonstrated that androgen deprivation results in activation/overexpression of Akt, <e1> COX-2 </e1> , and MMP-9 in cells.\n\n###\n\n", "completion": " COX-2\nprostate cancer\nfalse END"}
{"id": 173, "relation": "1", "prompt": "R-(+) equol and S-(-) equol inhibited motility and invasion in <e2> PC3 </e2> and DU145 cells, while the most strong effect was observed in PC3 cells by R-(+) equol, which might regulated by the activation of <e1> estrogen receptor-alpha </e1> .\n\n###\n\n", "completion": " estrogen receptor-alpha\nPC3\ntrue END"}
{"id": 174, "relation": "0", "prompt": "Induction of <e1> p27 </e1> (kip1) by 2,4,3',5'- tetramethoxystilbene is regulated by protein phosphatase 2A-dependent Akt dephosphorylation in <e2> PC-3 </e2> prostate cancer cells.\n\n###\n\n", "completion": " p27\nPC-3\nfalse END"}
{"id": 175, "relation": "0", "prompt": "Induction of p27( <e1> kip1 </e1> ) by 2,4,3',5'- tetramethoxystilbene is regulated by protein phosphatase 2A-dependent Akt dephosphorylation in <e2> PC-3 </e2> prostate cancer cells.\n\n###\n\n", "completion": " kip1\nPC-3\nfalse END"}
{"id": 176, "relation": "1", "prompt": "These results suggest that TMS may inhibit the cell cycle through induction of p27( <e1> kip1 </e1> ), leading to apoptotic cell death in <e2> PC-3 </e2> prostate cancer cells.\n\n###\n\n", "completion": " kip1\nPC-3\ntrue END"}
{"id": 177, "relation": "1", "prompt": "These results suggest that TMS may inhibit the cell cycle through induction of <e1> p27 </e1> (kip1), leading to apoptotic cell death in <e2> PC-3 </e2> prostate cancer cells.\n\n###\n\n", "completion": " p27\nPC-3\ntrue END"}
{"id": 178, "relation": "0", "prompt": "Our results support ongoing therapeutic attempts of <e1> EGFR </e1> inhibition in subgroups of patients with <e2> prostate cancer </e2> .\n\n###\n\n", "completion": " EGFR\nprostate cancer\nfalse END"}
{"id": 179, "relation": "0", "prompt": "We also found that the expression of tumour necrosis factor receptor 2 and death receptor 3 ( <e1> DR3 </e1> ) was increased in <e2> PC3 </e2> cells, and the expression of FAS and DR3 was increased in SW620 cells by co-culture with NK-92 cells.\n\n###\n\n", "completion": " DR3\nPC3\nfalse END"}
{"id": 180, "relation": "0", "prompt": "We also found that the expression of tumour necrosis factor receptor 2 and death receptor 3 ( <e1> DR3 </e1> ) was increased in <e2> PC3 </e2> cells, and the expression of FAS and DR3 was increased in SW620 cells by co-culture with NK-92 cells.\n\n###\n\n", "completion": " DR3\nPC3\nfalse END"}
{"id": 181, "relation": "0", "prompt": "We also found that the expression of <e1> tumour necrosis factor receptor 2 and death receptor 3 </e1> (DR3) was increased in <e2> PC3 </e2> cells, and the expression of FAS and DR3 was increased in SW620 cells by co-culture with NK-92 cells.\n\n###\n\n", "completion": " tumour necrosis factor receptor 2 and death receptor 3\nPC3\nfalse END"}
{"id": 182, "relation": "0", "prompt": "We also found that the expression of tumour necrosis factor receptor 2 and death receptor 3 (DR3) was increased in <e2> PC3 </e2> cells, and the expression of <e1> FAS </e1> and DR3 was increased in SW620 cells by co-culture with NK-92 cells.\n\n###\n\n", "completion": " FAS\nPC3\nfalse END"}
{"id": 183, "relation": "0", "prompt": "Evaluation of alterations in the level of the five major electrophoretic fractions of serum proteins (albumin, alpha 1-, alpha 2-, beta- and gamma-globulin) in 18 patients with <e2> prostatic cancer </e2> prior to and following cryoprostatectomy disclosed: (i) a progressive increase in the level of alpha 2- and beta-globulin and the incidence of patients possessing statistically significant (p less than 0.05) elevations in these proteins with a progression of the stage of their malignancy; (ii) a significant decrease in albumin, alpha 2- and beta-globulin and increase in alpha 1- and gamma-globulin from their preoperative levels following cryoprostatectomy in patients with metastatic disease (stage III) in association with a favorable clinical response; (iii) an overall significant decrease in albumin and alpha 2-globulin and increase in <e1> alpha 1-globulin </e1> from their preoperative levels and (iv) a general association of decreases in albumin (83% of the patients) and alpha 2-globulin (92%) and gamma-globulin (75%) with a favorable clinical response following cryoprostatectomy.\n\n###\n\n", "completion": " alpha 1-globulin\nprostatic cancer\nfalse END"}
{"id": 184, "relation": "0", "prompt": "Evaluation of alterations in the level of the five major electrophoretic fractions of serum proteins ( <e1> albumin </e1> , alpha 1-, alpha 2-, beta- and gamma-globulin) in 18 patients with <e2> prostatic cancer </e2> prior to and following cryoprostatectomy disclosed: (i) a progressive increase in the level of alpha 2- and beta-globulin and the incidence of patients possessing statistically significant (p less than 0.05) elevations in these proteins with a progression of the stage of their malignancy; (ii) a significant decrease in albumin, alpha 2- and beta-globulin and increase in alpha 1- and gamma-globulin from their preoperative levels following cryoprostatectomy in patients with metastatic disease (stage III) in association with a favorable clinical response; (iii) an overall significant decrease in albumin and alpha 2-globulin and increase in alpha 1-globulin from their preoperative levels and (iv) a general association of decreases in albumin (83% of the patients) and alpha 2-globulin (92%) and gamma-globulin (75%) with a favorable clinical response following cryoprostatectomy.\n\n###\n\n", "completion": " albumin\nprostatic cancer\nfalse END"}
{"id": 185, "relation": "0", "prompt": "Evaluation of alterations in the level of the five major electrophoretic fractions of serum proteins (albumin, alpha 1-, alpha 2-, beta- and gamma-globulin) in 18 patients with <e2> prostatic cancer </e2> prior to and following cryoprostatectomy disclosed: (i) a progressive increase in the level of alpha 2- and beta-globulin and the incidence of patients possessing statistically significant (p less than 0.05) elevations in these proteins with a progression of the stage of their malignancy; (ii) a significant decrease in albumin, alpha 2- and beta-globulin and increase in <e1> alpha 1- and gamma-globulin </e1> from their preoperative levels following cryoprostatectomy in patients with metastatic disease (stage III) in association with a favorable clinical response; (iii) an overall significant decrease in albumin and alpha 2-globulin and increase in alpha 1-globulin from their preoperative levels and (iv) a general association of decreases in albumin (83% of the patients) and alpha 2-globulin (92%) and gamma-globulin (75%) with a favorable clinical response following cryoprostatectomy.\n\n###\n\n", "completion": " alpha 1- and gamma-globulin\nprostatic cancer\nfalse END"}
{"id": 186, "relation": "0", "prompt": "Evaluation of alterations in the level of the five major electrophoretic fractions of serum proteins (albumin, alpha 1-, alpha 2-, beta- and gamma-globulin) in 18 patients with <e2> prostatic cancer </e2> prior to and following cryoprostatectomy disclosed: (i) a progressive increase in the level of alpha 2- and beta-globulin and the incidence of patients possessing statistically significant (p less than 0.05) elevations in these proteins with a progression of the stage of their malignancy; (ii) a significant decrease in albumin, alpha 2- and beta-globulin and increase in alpha 1- and gamma-globulin from their preoperative levels following cryoprostatectomy in patients with metastatic disease (stage III) in association with a favorable clinical response; (iii) an overall significant decrease in albumin and <e1> alpha 2-globulin </e1> and increase in alpha 1-globulin from their preoperative levels and (iv) a general association of decreases in albumin (83% of the patients) and alpha 2-globulin (92%) and gamma-globulin (75%) with a favorable clinical response following cryoprostatectomy.\n\n###\n\n", "completion": " alpha 2-globulin\nprostatic cancer\nfalse END"}
{"id": 187, "relation": "0", "prompt": "Evaluation of alterations in the level of the five major electrophoretic fractions of serum proteins (albumin, alpha 1-, alpha 2-, beta- and gamma-globulin) in 18 patients with <e2> prostatic cancer </e2> prior to and following cryoprostatectomy disclosed: (i) a progressive increase in the level of <e1> alpha 2- and beta-globulin </e1> and the incidence of patients possessing statistically significant (p less than 0.05) elevations in these proteins with a progression of the stage of their malignancy; (ii) a significant decrease in albumin, alpha 2- and beta-globulin and increase in alpha 1- and gamma-globulin from their preoperative levels following cryoprostatectomy in patients with metastatic disease (stage III) in association with a favorable clinical response; (iii) an overall significant decrease in albumin and alpha 2-globulin and increase in alpha 1-globulin from their preoperative levels and (iv) a general association of decreases in albumin (83% of the patients) and alpha 2-globulin (92%) and gamma-globulin (75%) with a favorable clinical response following cryoprostatectomy.\n\n###\n\n", "completion": " alpha 2- and beta-globulin\nprostatic cancer\nfalse END"}
{"id": 188, "relation": "0", "prompt": "Evaluation of alterations in the level of the five major electrophoretic fractions of serum proteins (albumin, alpha 1-, alpha 2-, beta- and gamma-globulin) in 18 patients with <e2> prostatic cancer </e2> prior to and following cryoprostatectomy disclosed: (i) a progressive increase in the level of alpha 2- and beta-globulin and the incidence of patients possessing statistically significant (p less than 0.05) elevations in these proteins with a progression of the stage of their malignancy; (ii) a significant decrease in albumin, alpha 2- and beta-globulin and increase in alpha 1- and gamma-globulin from their preoperative levels following cryoprostatectomy in patients with metastatic disease (stage III) in association with a favorable clinical response; (iii) an overall significant decrease in albumin and alpha 2-globulin and increase in <e1> alpha 1-globulin </e1> from their preoperative levels and (iv) a general association of decreases in albumin (83% of the patients) and alpha 2-globulin (92%) and gamma-globulin (75%) with a favorable clinical response following cryoprostatectomy.\n\n###\n\n", "completion": " alpha 1-globulin\nprostatic cancer\nfalse END"}
{"id": 189, "relation": "0", "prompt": "Evaluation of alterations in the level of the five major electrophoretic fractions of serum proteins ( <e1> albumin </e1> , alpha 1-, alpha 2-, beta- and gamma-globulin) in 18 patients with <e2> prostatic cancer </e2> prior to and following cryoprostatectomy disclosed: (i) a progressive increase in the level of alpha 2- and beta-globulin and the incidence of patients possessing statistically significant (p less than 0.05) elevations in these proteins with a progression of the stage of their malignancy; (ii) a significant decrease in albumin, alpha 2- and beta-globulin and increase in alpha 1- and gamma-globulin from their preoperative levels following cryoprostatectomy in patients with metastatic disease (stage III) in association with a favorable clinical response; (iii) an overall significant decrease in albumin and alpha 2-globulin and increase in alpha 1-globulin from their preoperative levels and (iv) a general association of decreases in albumin (83% of the patients) and alpha 2-globulin (92%) and gamma-globulin (75%) with a favorable clinical response following cryoprostatectomy.\n\n###\n\n", "completion": " albumin\nprostatic cancer\nfalse END"}
{"id": 190, "relation": "0", "prompt": "<e1> Trefoil factor 3 </e1> is overexpressed in human <e2> prostate cancer </e2> .\n\n###\n\n", "completion": " Trefoil factor 3\nprostate cancer\nfalse END"}
{"id": 191, "relation": "0", "prompt": "Recent cDNA array analyses suggest that <e1> human intestinal trefoil factor 3 </e1> (TFF3) may be overexpressed in human <e2> prostate cancer </e2> .\n\n###\n\n", "completion": " human intestinal trefoil factor 3\nprostate cancer\nfalse END"}
{"id": 192, "relation": "0", "prompt": "Recent cDNA array analyses suggest that human intestinal trefoil factor 3 ( <e1> TFF3 </e1> ) may be overexpressed in human <e2> prostate cancer </e2> .\n\n###\n\n", "completion": " TFF3\nprostate cancer\nfalse END"}
{"id": 193, "relation": "0", "prompt": "These studies validate that <e1> TFF3 </e1> is overexpressed in a subset of primary and metastic <e2> prostate cancers </e2> .\n\n###\n\n", "completion": " TFF3\nprostate cancers\nfalse END"}
{"id": 194, "relation": "0", "prompt": "Furthermore, E1 induced a twofold increase in connexin 43 (Cx43), whereas forskolin caused a 50% reduction in <e1> Cx32 </e1> expression in <e2> RWPE-1 </e2> cells.\n\n###\n\n", "completion": " Cx32\nRWPE-1\nfalse END"}
{"id": 195, "relation": "0", "prompt": "Furthermore, E1 induced a twofold increase in connexin 43 ( <e1> Cx43 </e1> ), whereas forskolin caused a 50% reduction in Cx32 expression in <e2> RWPE-1 </e2> cells.\n\n###\n\n", "completion": " Cx43\nRWPE-1\nfalse END"}
{"id": 196, "relation": "0", "prompt": "Furthermore, E1 induced a twofold increase in <e1> connexin 43 </e1> (Cx43), whereas forskolin caused a 50% reduction in Cx32 expression in <e2> RWPE-1 </e2> cells.\n\n###\n\n", "completion": " connexin 43\nRWPE-1\nfalse END"}
{"id": 197, "relation": "0", "prompt": "Arsenite induces <e1> HIF-1alpha </e1> and VEGF through PI3K, Akt and reactive oxygen species in <e2> DU145 </e2> human prostate carcinoma cells.\n\n###\n\n", "completion": " HIF-1alpha\nDU145\nfalse END"}
{"id": 198, "relation": "0", "prompt": "Arsenite induces HIF-1alpha and <e1> VEGF </e1> through PI3K, Akt and reactive oxygen species in <e2> DU145 </e2> human prostate carcinoma cells.\n\n###\n\n", "completion": " VEGF\nDU145\nfalse END"}
{"id": 199, "relation": "0", "prompt": "Arsenite induces HIF-1alpha and VEGF through <e1> PI3K </e1> , Akt and reactive oxygen species in <e2> DU145 </e2> human prostate carcinoma cells.\n\n###\n\n", "completion": " PI3K\nDU145\nfalse END"}
{"id": 200, "relation": "0", "prompt": "Arsenite induces HIF-1alpha and VEGF through PI3K, <e1> Akt </e1> and reactive oxygen species in <e2> DU145 </e2> human prostate carcinoma cells.\n\n###\n\n", "completion": " Akt\nDU145\nfalse END"}
{"id": 201, "relation": "0", "prompt": "Here we demonstrate that arsenite induces the expression of <e1> HIF-1alpha </e1> but not HIF-1beta subunit in <e2> DU145 </e2> human prostate carcinoma cells.\n\n###\n\n", "completion": " HIF-1alpha\nDU145\nfalse END"}
{"id": 202, "relation": "0", "prompt": "Here we demonstrate that arsenite induces the expression of HIF-1alpha but not <e1> HIF-1beta subunit </e1> in <e2> DU145 </e2> human prostate carcinoma cells.\n\n###\n\n", "completion": " HIF-1beta subunit\nDU145\nfalse END"}
{"id": 203, "relation": "0", "prompt": "The differentiation-related gene 1, <e1> Drg1 </e1> , is markedly upregulated by androgens in <e2> LNCaP </e2> prostatic adenocarcinoma cells.\n\n###\n\n", "completion": " Drg1\nLNCaP\nfalse END"}
{"id": 204, "relation": "0", "prompt": "Basal levels and adrenocorticotropic hormone (ACTH)-induced increments (delta-values) of serum cortisol, dehydroepiandrosterone (DHA), dehydroepiandrosterone sulfate (DHAS), 4-androstene-3, 17-dione (A4), and 17-hydroxyprogesterone (170HP); basal testosterone (T), <e1> luteinizing hormone </e1> (LH), serum ASAT, gamma-GT, and albumin were measured in <e2> prostatic cancer </e2> patients before and after 6 months of treatment with LH-RH-agonist, with flutamide, and with LH-RH-agonist + flutamide, respectively.\n\n###\n\n", "completion": " luteinizing hormone\nprostatic cancer\nfalse END"}
{"id": 205, "relation": "0", "prompt": "Basal levels and adrenocorticotropic hormone ( <e1> ACTH </e1> )-induced increments (delta-values) of serum cortisol, dehydroepiandrosterone (DHA), dehydroepiandrosterone sulfate (DHAS), 4-androstene-3, 17-dione (A4), and 17-hydroxyprogesterone (170HP); basal testosterone (T), luteinizing hormone (LH), serum ASAT, gamma-GT, and albumin were measured in <e2> prostatic cancer </e2> patients before and after 6 months of treatment with LH-RH-agonist, with flutamide, and with LH-RH-agonist + flutamide, respectively.\n\n###\n\n", "completion": " ACTH\nprostatic cancer\nfalse END"}
{"id": 206, "relation": "0", "prompt": "Basal levels and <e1> adrenocorticotropic hormone </e1> (ACTH)-induced increments (delta-values) of serum cortisol, dehydroepiandrosterone (DHA), dehydroepiandrosterone sulfate (DHAS), 4-androstene-3, 17-dione (A4), and 17-hydroxyprogesterone (170HP); basal testosterone (T), luteinizing hormone (LH), serum ASAT, gamma-GT, and albumin were measured in <e2> prostatic cancer </e2> patients before and after 6 months of treatment with LH-RH-agonist, with flutamide, and with LH-RH-agonist + flutamide, respectively.\n\n###\n\n", "completion": " adrenocorticotropic hormone\nprostatic cancer\nfalse END"}
{"id": 207, "relation": "0", "prompt": "The most prominent of these progressive changes is the up-regulation of <e1> AR </e1> that occurs in &gt;90% <e2> of prostate canc </e2> ers.\n\n###\n\n", "completion": " AR\nof prostate canc\nfalse END"}
{"id": 208, "relation": "1", "prompt": "These events result in increased accumulation of <e1> AR </e1> and thus enhanced growth of <e2> prostate cancer </e2> cells at low levels of androgen.\n\n###\n\n", "completion": " AR\nprostate cancer\ntrue END"}
{"id": 209, "relation": "0", "prompt": "About 50% of <e2> prostate cancers </e2> have TMPRSS2- <e1> ERG </e1> fusions with concurrent ERG overexpression.\n\n###\n\n", "completion": " ERG\nprostate cancers\nfalse END"}
{"id": 210, "relation": "0", "prompt": "Inhibition of ligand-mediated <e1> HER2 </e1> activation in androgen-independent <e2> prostate cancer </e2> .\n\n###\n\n", "completion": " HER2\nprostate cancer\nfalse END"}
{"id": 211, "relation": "0", "prompt": "In both <e2> PC-3 </e2> and PC-3U cells, TGF-beta 1 was found to stimulate the induction of fibronectin and plasminogen activator inhibitor-1 and the expression of <e1> junB mRNA </e1> , and PMA did not affect these responses.\n\n###\n\n", "completion": " junB mRNA\nPC-3\nfalse END"}
{"id": 212, "relation": "0", "prompt": "In both <e2> PC-3 </e2> and PC-3U cells, TGF-beta 1 was found to stimulate the induction of fibronectin and <e1> plasminogen activator inhibitor-1 </e1> and the expression of junB mRNA, and PMA did not affect these responses.\n\n###\n\n", "completion": " plasminogen activator inhibitor-1\nPC-3\nfalse END"}
{"id": 213, "relation": "0", "prompt": "In both <e2> PC-3 </e2> and PC-3U cells, TGF-beta 1 was found to stimulate the induction of <e1> fibronectin </e1> and plasminogen activator inhibitor-1 and the expression of junB mRNA, and PMA did not affect these responses.\n\n###\n\n", "completion": " fibronectin\nPC-3\nfalse END"}
{"id": 214, "relation": "0", "prompt": "Similarly, activation of the <e1> AR </e1> by phosphorylated protein kinase B, Akt, has also been reported in <e2> prostate cancer </e2> .\n\n###\n\n", "completion": " AR\nprostate cancer\nfalse END"}
{"id": 215, "relation": "0", "prompt": "Similarly, activation of the <e1> AR </e1> by phosphorylated protein kinase B, Akt, has also been reported in <e2> prostate cancer </e2> .\n\n###\n\n", "completion": " AR\nprostate cancer\nfalse END"}
{"id": 216, "relation": "0", "prompt": "Overexpression of manganese <e1> superoxide dismutase </e1> in <e2> DU145 </e2> human prostate carcinoma cells has multiple effects on cell phenotype.\n\n###\n\n", "completion": " superoxide dismutase\nDU145\nfalse END"}
{"id": 217, "relation": "0", "prompt": "<e2> DU145 </e2> human prostate carcinoma cells were transfected with the cDNA for manganese superoxide dismutase ( <e1> MnSOD </e1> ), and two clones overexpressing MnSOD activity were subsequently characterized by comparison with parental and plasmid control-transfected cells.\n\n###\n\n", "completion": " MnSOD\nDU145\nfalse END"}
{"id": 218, "relation": "0", "prompt": "Our results suggest novel mechanisms by which <e1> MnSOD </e1> overexpression may modulate the malignant phenotype, with potential applications in developing new therapies for <e2> prostate cancer </e2> .\n\n###\n\n", "completion": " MnSOD\nprostate cancer\nfalse END"}
{"id": 219, "relation": "0", "prompt": "Overexpression of <e1> p45-sErbB3 </e1> in the osteolytic prostate cancer cell line <e2> PC-3 </e2> converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice.\n\n###\n\n", "completion": " p45-sErbB3\nPC-3\nfalse END"}
{"id": 220, "relation": "0", "prompt": "Accumulation of <e1> p53 protein </e1> in the absence of detectable mutant p53 was recognized more often in <e2> prostate cancer </e2> than in any other tumor examined.\n\n###\n\n", "completion": " p53 protein\nprostate cancer\nfalse END"}
{"id": 221, "relation": "1", "prompt": "L-mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and <e1> N-myc downstream regulated gene 1 </e1> in <e2> prostate carcinoma </e2> cells.\n\n###\n\n", "completion": " N-myc downstream regulated gene 1\nprostate carcinoma\ntrue END"}
{"id": 222, "relation": "1", "prompt": "L-mimosine blocks cell proliferation via upregulation of <e1> B-cell translocation gene 2 </e1> and N-myc downstream regulated gene 1 in <e2> prostate carcinoma </e2> cells.\n\n###\n\n", "completion": " B-cell translocation gene 2\nprostate carcinoma\ntrue END"}
{"id": 223, "relation": "0", "prompt": "Immunoblot assays indicated that hypoxia and L-mimosine stabilized hypoxia-inducible factor-1 \u03b1 (HIF-1\u03b1) and induced Btg2 and <e1> Ndrg1 protein </e1> expression, but downregulated protein levels of cyclin A in both <e2> PC-3 </e2> and LNCaP cells.\n\n###\n\n", "completion": " Ndrg1 protein\nPC-3\nfalse END"}
{"id": 224, "relation": "0", "prompt": "Immunoblot assays indicated that hypoxia and L-mimosine stabilized hypoxia-inducible factor-1 \u03b1 (HIF-1\u03b1) and induced <e1> Btg2 </e1> and Ndrg1 protein expression, but downregulated protein levels of cyclin A in both <e2> PC-3 </e2> and LNCaP cells.\n\n###\n\n", "completion": " Btg2\nPC-3\nfalse END"}
{"id": 225, "relation": "0", "prompt": "Immunoblot assays indicated that hypoxia and L-mimosine stabilized hypoxia-inducible factor-1 \u03b1 (HIF-1\u03b1) and induced <e1> Btg2 </e1> and Ndrg1 protein expression, but downregulated protein levels of cyclin A in both <e2> PC-3 </e2> and LNCaP cells.\n\n###\n\n", "completion": " Btg2\nPC-3\nfalse END"}
{"id": 226, "relation": "0", "prompt": "L-mimosine treatment decreased <e1> cyclin D1 </e1> protein in <e2> PC-3 </e2> cells, but not in LNCaP cells.\n\n###\n\n", "completion": " cyclin D1\nPC-3\nfalse END"}
{"id": 227, "relation": "0", "prompt": "Dimethyloxalylglycine, a pan-prolyl hydroxylase inhibitor, also induced <e1> Btg2 </e1> and Ndrg1 protein expression in <e2> LNCaP </e2> cells.\n\n###\n\n", "completion": " Btg2\nLNCaP\nfalse END"}
{"id": 228, "relation": "0", "prompt": "Dimethyloxalylglycine, a pan-prolyl hydroxylase inhibitor, also induced Btg2 and <e1> Ndrg1 protein </e1> expression in <e2> LNCaP </e2> cells.\n\n###\n\n", "completion": " Ndrg1 protein\nLNCaP\nfalse END"}
{"id": 229, "relation": "0", "prompt": "Dimethyloxalylglycine, a pan-prolyl hydroxylase inhibitor, also induced <e1> Btg2 </e1> and Ndrg1 protein expression in <e2> LNCaP </e2> cells.\n\n###\n\n", "completion": " Btg2\nLNCaP\nfalse END"}
{"id": 230, "relation": "0", "prompt": "Knockdown of <e1> HIF-1\u03b1 </e1> attenuated the increasing protein levels of both Btg2 and Ndrg1 by hypoxia or L-mimosine in <e2> LNCaP </e2> cells.\n\n###\n\n", "completion": " HIF-1\u03b1\nLNCaP\nfalse END"}
{"id": 231, "relation": "0", "prompt": "Knockdown of HIF-1\u03b1 attenuated the increasing protein levels of both <e1> Btg2 </e1> and Ndrg1 by hypoxia or L-mimosine in <e2> LNCaP </e2> cells.\n\n###\n\n", "completion": " Btg2\nLNCaP\nfalse END"}
{"id": 232, "relation": "0", "prompt": "Knockdown of HIF-1\u03b1 attenuated the increasing protein levels of both Btg2 and <e1> Ndrg1 </e1> by hypoxia or L-mimosine in <e2> LNCaP </e2> cells.\n\n###\n\n", "completion": " Ndrg1\nLNCaP\nfalse END"}
{"id": 233, "relation": "1", "prompt": "L-mimosine enhanced expression of Btg2 and <e1> Ndrg1 </e1> , which attenuated cell proliferation of the <e2> PC-3 </e2> and LNCaP prostate carcinoma cells.\n\n###\n\n", "completion": " Ndrg1\nPC-3\ntrue END"}
{"id": 234, "relation": "1", "prompt": "L-mimosine enhanced expression of <e1> Btg2 </e1> and Ndrg1, which attenuated cell proliferation of the <e2> PC-3 </e2> and LNCaP prostate carcinoma cells.\n\n###\n\n", "completion": " Btg2\nPC-3\ntrue END"}
{"id": 235, "relation": "0", "prompt": "Further, treating specific inhibitors for PI3K (Wortmannin) or JNK (SP600125) to <e2> PC-3 </e2> cells could reduce the protein expressions of MMP-2 and <e1> MMP-9 </e1> .\n\n###\n\n", "completion": " MMP-9\nPC-3\nfalse END"}
{"id": 236, "relation": "0", "prompt": "Further, treating specific inhibitors for PI3K (Wortmannin) or JNK (SP600125) to <e2> PC-3 </e2> cells could reduce the protein expressions of <e1> MMP-2 </e1> and MMP-9.\n\n###\n\n", "completion": " MMP-2\nPC-3\nfalse END"}
{"id": 237, "relation": "1", "prompt": "These results showed fisetin could inhibit the metastatic ability of <e2> PC-3 </e2> by reducing MMP-2 and <e1> MMP-9 </e1> expressions through suppressing phosphoinositide 3-kinase/Akt (PI3K/Akt) and JNK signaling pathways.\n\n###\n\n", "completion": " MMP-9\nPC-3\ntrue END"}
{"id": 238, "relation": "1", "prompt": "These results showed fisetin could inhibit the metastatic ability of <e2> PC-3 </e2> by reducing <e1> MMP-2 </e1> and MMP-9 expressions through suppressing phosphoinositide 3-kinase/Akt (PI3K/Akt) and JNK signaling pathways.\n\n###\n\n", "completion": " MMP-2\nPC-3\ntrue END"}
{"id": 239, "relation": "0", "prompt": "The expression of the <e1> p75 neurotrophin receptor </e1> (p75NTR) is diminished in epithelial cells during progression of <e2> prostate cancer </e2> in vivo and in vitro.\n\n###\n\n", "completion": " p75 neurotrophin receptor\nprostate cancer\nfalse END"}
{"id": 240, "relation": "0", "prompt": "The expression of the p75 neurotrophin receptor ( <e1> p75NTR </e1> ) is diminished in epithelial cells during progression of <e2> prostate cancer </e2> in vivo and in vitro.\n\n###\n\n", "completion": " p75NTR\nprostate cancer\nfalse END"}
{"id": 241, "relation": "0", "prompt": "Hence, re-expression of the p75NTR appears to partially reverse de-differentiation of <e2> prostate cancer </e2> cells by up-regulating the expression of CRABPI for localized sequestration of retinoids that are available to newly up-regulated <e1> RAR-beta </e1> , RXR-alpha, and RXR-beta.\n\n###\n\n", "completion": " RAR-beta\nprostate cancer\nfalse END"}
{"id": 242, "relation": "1", "prompt": "Hence, re-expression of the p75NTR appears to partially reverse de-differentiation of <e2> prostate cancer </e2> cells by up-regulating the expression of <e1> CRABPI </e1> for localized sequestration of retinoids that are available to newly up-regulated RAR-beta, RXR-alpha, and RXR-beta.\n\n###\n\n", "completion": " CRABPI\nprostate cancer\ntrue END"}
{"id": 243, "relation": "1", "prompt": "Ubiquitous <e1> mitochondrial creatine kinase </e1> is overexpressed in the conditioned medium and the extract of <e2> LNCaP </e2> lineaged androgen independent cell lines and facilitates prostate cancer progression.\n\n###\n\n", "completion": " mitochondrial creatine kinase\nLNCaP\ntrue END"}
{"id": 244, "relation": "0", "prompt": "<e1> uMtCK </e1> was up-regulated in AIPC cells and in human <e2> prostate cancer </e2> tissues at WHO grade III.\n\n###\n\n", "completion": " uMtCK\nprostate cancer\nfalse END"}
{"id": 245, "relation": "0", "prompt": "Exogenous uMtCK in <e2> LNCaP </e2> cells surprisingly contributed to overproduction of <e1> ROS </e1> , activation of Akt signaling pathway and more aggressive phenotypes including androgen independence development.\n\n###\n\n", "completion": " ROS\nLNCaP\nfalse END"}
{"id": 246, "relation": "0", "prompt": "Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells ( <e2> PC-3 </e2> ) are associated with increase in <e1> p21 </e1> and hypophosphorylated retinoblastoma proteins expression.\n\n###\n\n", "completion": " p21\nPC-3\nfalse END"}
